Genetic distinctions between types 1 and 2 autoimmune hepatitis

American Journal of Gastroenterology

Volumn 92, Issue 12 SUPPL., 1997, Pages 2197-2200

  Czaja, Albert J ^a   Kruger, Martin ^b   Santrach, Paula J ^b   Breanndan Moore, S ^b   Manns, Michael P ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; AUTOIMMUNE HEPATITIS; DISEASE CLASSIFICATION; DNA DETERMINATION; FEMALE; GENETIC SUSCEPTIBILITY; GERMANY; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES;

ADULT; ALLELES; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HEPATITIS, AUTOIMMUNE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 0030833915     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Czaja AJ. Chronic active hepatitis: The challenge for a new nomenclature. Ann Intern Med 1993;119:510-7.
2. Czaja AJ, Manns MP. The validity and importance of subtypes of autoimmune hepatitis: A point of view. Am J Gastroenterol 1995;90: 1206-11.
3. Czaja AJ. Autoimmune hepatitis: Evolving concepts and treatment strategies. Dig Dis Sci 1995;40:435-56.
4. Homberg J-C, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: A second type of "autoimmune" hepatitis. Hepatology 1987;7:1333-9.
5. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992;103:1290-5.
6. Lunel F, Abuaf N, Frangeul L, et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992;16:630-6.
7. Manns MP, Griffin KJ, Sullivan KF, et al. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991;88:1370-8.
8. Manns MP. Cytoplasmic autoantigens in autoimmune hepatitis: Molecular analysis and clinical relevance. Semin Liver Dis 1991;11:205-14.
9. Strettel MDJ, Donaldson PT, Thomson LJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997;112:2028-35.
10. Czaja AJ, Strettell MDJ, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997;25:317-23.
11. Manns MP, Kruger M. Immunogenetics of chronic liver diseases. Gastroenterology 1994;106:1676-97.
12. Johnson PJ, McFarlane IG, Alvarez F, et al. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
13. Czaja AJ, Carpenter HA. Validation of a scoring system for the diagnosis of autoimmune hepatitis. Dig Dis Sci 1996;41:305-14.
14. Czaja AJ, Nishioka M, Morshed SA, et al. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994;107:200-7.
15. Czaja AJ, Cassani F, Cataleta M, et al. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996; 24:1068-73.
16. Czaja AJ, Taswell H, Rakela J, et al. Duration and specificity of antibodies to hepatitis C virus in chronic active hepatitis. Gastroenterology 1992;102:1675-9.
17. Meyer zum Bushenfelde K-H, Hutteroth TH. Autoantibodies against liver membrane antigens in chronic active liver disease. In: Eddleston ALWF, Weber JCP, Williams R, eds. Immune reactions in liver disease. Kent: Pitman Medical Publishing Co., 1979:12-20.
18. Mackay IR. Genetic aspects of immunologically mediated liver disease. Semin Liver Dis 1984;4:13-25.
19. Mackay IR. Autoimmune diseases of the liver: Chronic active hepatitis and primary biliary cirrhosis. In: Rose NR, Mackay IR, eds. The autoimmune diseases. Orlando: Academic Press, Inc., 1985:291-337.
20. Czaja AJ. Clinical aspects of autoimmune hepatitis in North America. In: Nishioka M, Toda G, Zeniya M, eds. Autoimmune hepatitis. Amsterdam: Elsevier Science B.V., 1994:27-43.
21. Ryder LP, Andersen E, Svejgaard A. An HLA map of Europe. Hum Hered 1978;28:171-200.
22. Donaldson PT, Doherty DG, Hayllar KM, et al. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991;13: 701-6.
23. Doherty DG, Donaldson PT, Underhill JA, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994;19:609-15.
24. Donaldson P, Doherty D, Underhill J, et al. The molecular genetics of autoimmune liver disease. Hepatology 1994;20:225-39.
25. Santamaria P, Gehz RC, Bryan MK, et al. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. J Immunol 1989;143:913-22.
26. Miller LC, Kaplan MM. Serum interleukin-2 and tumor necrosis factor-α in primary biliary cirrhosis: Decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol 1992;87:465-70.
27. Czaja AJ. Autoimmune hepatitis. Curr Opin Gastroenterol 1997;13: 248-56.
28. Manabe K, Hibberd ML, Donaldson PT, et al. T-cell receptor constant β germline gene polymorphisms and susceptibility to autoimmune hepatitis. Gastroenterology 1994;106:1321-5.
29. Walser-Kuntz DR, Weyland CM, Fulbright JW, et al. HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T cells. Hum Immunol 1995;44:203-9.